Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2011NeurologyOpen Access

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRobert G. MillerLoughborough UniversityDMDan H. MooreRutgers, The State University of New JerseyDFDalles A. ForshewCalifornia Pacific Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miller et al. (2011) studied this question.

synapsesocial.com/papers/6aa255d6f92980b6ef322ea5https://doi.org/10.1212/wnl.0b013e31822dc7a5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lithium carbonate in amyotrophic lateral sclerosis2010 · 99 citations
  2. 2Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III2009 · 236 citations
  3. 3A randomized sequential trial of creatine in amyotrophic lateral sclerosis2003 · 284 citations
  4. 4Lithium delays progression of amyotrophic lateral sclerosis2008 · 554 citations
  5. 5Lithium induces autophagy by inhibiting inositol monophosphatase2005 · 999 citations